Obez Hastalarda Mide Balonu Uygulaması
Özet
Referanslar
Imaz I, Martínez-Cervell C, García-Alvarez EE, Sendra-Gutiérrez JM, González-Enríquez J. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18(7):841–6.
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894:i.
Ribeiro da Silva J, Proença L, Rodrigues A, Pinho R, Ponte A, Rodrigues J, Sousa M, Almeida R, Carvalho J: Intragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy. GE Port J Gastroenterol 2018;25:236-242. doi: 10.1159/000485428
Dumonceau, JM. Evidence-based Review of the Bioenterics Intragastric Balloon for Weight Loss. OBES SURG 18, 1611 (2008).
Mathus-Vliegen EM, Tytgat GN: Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005;61:19-27.
Bilge H, Yigitbas H, Ercetin C, et al. Effect of laparoscopic greater curve plication on glucose and lipid metabolism in Turkish obese subjects. Bariatric Surgical Practice and Patient Care. 2016;11(1):20–4.
Evans JD, Scott MH. lntragastricballoon in the treatment of patienıs with morbidobesity. Br J Surg . 2001 Sep:88(9}: 1245-8.
Ulicny KS. Goldberg SJ. Harpcr WJ, orelitz JL, Podore PC. Fegelman RH. Surgicalcomplicaıions of the Garren-Edward s GastricBubble. SurgGynecolObstet 1988: 166:535-40.
MathusVliegen EM. Tytgat GN, VeldhuyzenOfferrnans EA. lntragastricballoon in the treatment of supermorbidobesity. Doubleblind. shamcontrolled, crossoverevaluation of 500-milliliter balloon .Gastroenterology 1990;99:362-9.
Zengin K. Ersoy Y. Şimşek O, Taşkın M. intragastrik Balon Uygulamalarının Morbid Obezite Tedavisindeki Yeri Çağdaş cerrahi Derg 2005;19(3):1 10-114.
Frutos MD, Morales MD, Lujan J, Hernandez Q, Valero G, Parrilla P. Intragastricballoonreduceslivervolume in super-obesepatients, facilitatingsubsequentlaparoscopicgastric bypass ObesSurg. 2007 : 17 (2): 150-4.
